AlphaFold predicted structure
PRPF8 · Q6P2Q9

Mean pLDDT
84.9/ 100
Confident
2,335 residues
Confidence breakdown
- Very high(≥ 90)44%
- Confident(70–90)47%
- Low(50–70)7%
- Very low(< 50)3%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
pre-mRNA processing factor 8
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
DDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownEarly onset or syndromic epilepsy
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedRetinal disorders
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownGlaucoma (developmental)
Structural eye disease
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedretinitis pigmentosa
Retinal dystrophy
autosomal dominant retinitis pigmentosa
retinal disorder
hereditary disease
eye disorder
complex neurodevelopmental disorder
dengue disease
neurodegenerative disease
clonal hematopoiesis
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Pre-mRNA-processing-splicing factor 8
Plays a role in pre-mRNA splicing as core component of precatalytic, catalytic and postcatalytic spliceosomal complexes, both of the predominant U2-type spliceosome and the minor U12-type spliceosome (PubMed:10411133, PubMed:11971955, PubMed:28076346, PubMed:28502770, PubMed:28781166, PubMed:29301961, PubMed:29360106, PubMed:29361316, PubMed:30315277, PubMed:30705154, PubMed:30728453). Functions as a scaffold that mediates the ordered assembly of spliceosomal proteins and snRNAs. Required for the assembly of the U4/U6-U5 tri-snRNP complex, a building block of the spliceosome. Functions as a scaffold that positions spliceosomal U2, U5 and U6 snRNAs at splice sites on pre-mRNA substrates, so that splicing can occur. Interacts with both the 5' and the 3' splice site
PRPF8 · Q6P2Q9

Mean pLDDT
84.9/ 100
Confident
2,335 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0